investigator_user
investigator
user
funding
collaborators
pending
menu
bell
message
arrow_up
arrow_down
filter
layers
globe
marker
add
arrow
close
download
edit
facebook
info
linkedin
minus
plus
save
share
search
sort
twitter
remove
user-plus
user-minus
Sign Up for Updates
Map
Countries
Cancer types
All cancers but non-melanoma skin cancer
Bladder
Brain, nervous system
Breast
Cervix uteri
Colorectum
Corpus uteri
Gallbladder
Hodgkin lymphoma
Kaposi sarcoma
Kidney, renal pelvis and ureter
Larynx
Leukaemia
Lip, oral cavity
Liver and intrahepatic bile ducts
Melanoma of skin
Multiple myeloma and immunoproliferative diseases
Nasopharynx
Non-Hodgkin lymphoma
Non-Melanoma skin cancer
Oesophagus
Other pharynx
Ovary
Pancreas
Prostate
Sarcoma
Stomach
Testis
Thymus
Thyroid
Trachea, bronchus and lung
Specialities
Hematology and hematologic malignancies
Palliative Care
Pathology
Pediatric oncology or childhood cancer
Radiation Oncology
Surgery / Surgical oncology
Blog
About
Login
Project leads
Collaborators
Deprive prostate cancer of DHEAS to prevent castration-recurrent prostate cancer
Yue Wu
0 Collaborator(s)
Funding source
National Institutes of Health (NIH)
Follow
+ Project
+ Post
+ Event
Info
People
Posts
Yue Wu
Roswell Park Cancer Institute
Buffalo, United States
Related projects
Antonio Fojo
Clinical, Basic, Translational and Kinetic Studies of Drug Action and Resistance
Prostate
Gustavo Ayala
Comprehensive Tumor Microenvironment Based Prediction Models in Prostate Cancer
Prostate
Radiation Oncology
Stephan Maier
Advanced Techniques For Rapid And Artifact-Resistant MR Diffusion Imaging
Prostate
Ah-Ng Tony Kong
Curcuma Longa: epigenetic effects in prostate and colon cancer
Prostate
Mark A Rubin
Towards Understanding Prostate Cancer Heterogeneity
Prostate
Pathology
Reginald D. Tucker-Seeley
Financial well-being following prostate cancer diagnosis
Prostate
Hsian-Rong Tseng
Thermoresponsive Nanovelcro CTC Purification System For Prostate Cancer Profiling
Prostate
Pathology
Shalendar Bhasin
A selective Androgen Receptor Modulator for Symptom Management in Prostate Cancer
Prostate
John V Frangioni
(PQC-5) Zwitterionic NIR/Zr-89 Agents for Prostate Cancer Staging and Treatment
Prostate
Pathology
Surgery / Surgical oncology